Additional mechanisms of aberrant pathway activation can be ligand-dependent, autocrine activation of the pathway, whereby cancer cells can upregulate the synthesis of the Shh ligand and stimulate Hh/GLI pathway activation. This evidence concerns the gene GLI1 and cancer.